Scinovex
review Open AccessTop 1% cited

Targeting the PI3K-Akt pathway in human cancer

Cancer Cell · 2003 · Vol. 4(4) · pp. 257–262
Ji LuoBrendan D. ManningLewis C. Cantley
PI3K/AKT/mTOR signaling in cancerCancer-related Molecular PathwaysCRISPR and Genetic EngineeringPI3K/AKT/mTOR pathwayDNA damageCell divisionBiologySenescenceCell growthCell biologyApoptosisCancer cellProtein kinase B

MeSH terms

AnimalsCell CycleCell DivisionCell SurvivalHumansNeoplasmsNeoplasms, ExperimentalPhosphorylationProto-Oncogene ProteinsSignal TransductionProtein Serine-Threonine KinasesPhosphatidylinositol 3-KinasesModels, AnimalProtein Interaction MappingProto-Oncogene Proteins c-akt

Funding

  • Howard Hughes Medical Institute
  • American Cancer Society
Citations
1,282
FWCI
21.30
field-weighted impact
References
72
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.